Cargando…

Molecular Alterations in Circulating Cell-Free DNA in Patients with Colorectal Adenoma or Carcinoma

PURPOSE: The aim of this study was to evaluate the clinical value of plasma cell-free DNA (cfDNA) in the diagnosis of colorectal cancer (CRC). PATIENTS AND METHODS: The plasma cfDNA and tissue DNA mutation profiles were investigated in 77 patients (9 colon polyps, 18 colon adenoma, 26 colon cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Ying, Chen, Yawei, Guo, Hao, Yu, Jianing, Chen, Yanhui, Liu, Yang, Lan, Ling, Li, Jian, Wang, Huaqing, Zhang, Henghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335290/ https://www.ncbi.nlm.nih.gov/pubmed/32636678 http://dx.doi.org/10.2147/CMAR.S244520

Ejemplares similares

Different primers for diagnosing circulating cell-free DNA of colorectal cancer
por: Shi, Hao, et al.
Publicado: (2020)

Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity
por: Myint, Ni Ni Moe, et al.
Publicado: (2018)

Circulating Concentrations of C-Peptide and Colorectal Adenoma
por: Choi, Yoon Ji, et al.
Publicado: (2014)

Role of circulating free DNA in colorectal cancer
por: Matikas, Alexios, et al.
Publicado: (2016)

Molecular Alterations of Circulating Cell-Free DNA in the Pathological Progression of Hepatocellular Carcinoma
por: Guo, Wenbo, et al.
Publicado: (2021)

DNA aneuploidy in colorectal adenomas.
por: van den Ingh, H. F., et al.
Publicado: (1987)

DNA aneuploidy in colorectal adenomas.
por: Quirke, P., et al.
Publicado: (1986)

Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers
por: Yang, Xin, et al.
Publicado: (2022)

5‐Hydroxymethylcytosine signature in circulating cell‐free DNA as a potential diagnostic factor for early‐stage colorectal cancer and precancerous adenoma
por: Xiao, ZeWen, et al.
Publicado: (2020)

Alterations of Gut Mycobiota Profiles in Adenoma and Colorectal Cancer
por: Gao, Renyuan, et al.
Publicado: (2022)

Multiple colorectal adenomas in Lynch syndrome
por: Jain, Ayushi, et al.
Publicado: (2022)

Genetic differences between lung metastases and liver metastases from left-sided microsatellite stable colorectal cancer: next generation sequencing and clinical implications
por: Wang, Zhenghang, et al.
Publicado: (2021)

Alterations of 5-hydroxymethylation in circulating cell-free DNA reflect molecular distinctions of subtypes of non-Hodgkin lymphoma
por: Chiu, Brian C.-H., et al.
Publicado: (2021)

Mutational landscape of circulating tumor DNA identifies distinct molecular features associated with therapeutic response in patients with metastatic colorectal cancer
por: Shi, Min, et al.
Publicado: (2022)

Associations of Circulating Inflammatory Biomarkers with Risk Factors for Colorectal Cancer in Colorectal Adenoma Patients
por: Hopkins, Myfanwy H., et al.
Publicado: (2012)

Molecular features of tumor-derived genetic alterations in circulating cell-free DNA in virtue of autopsy analysis
por: Koba, Hayato, et al.
Publicado: (2021)

Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations
por: Druliner, Brooke R., et al.
Publicado: (2018)

Consensus molecular subtype classification of colorectal adenomas
por: Komor, Malgorzata A, et al.
Publicado: (2018)

Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer
por: Tsai, Wen-Sy, et al.
Publicado: (2019)

Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review
por: Vymetalkova, Veronika, et al.
Publicado: (2018)

Clinical utility of circulating cell-free DNA in advanced colorectal cancer
por: Pereira, Allan A. Lima, et al.
Publicado: (2017)

Molecular analysis of cell-free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer
por: Zhang, Jie, et al.
Publicado: (2019)

Altered Tissue Metabolites Correlate with Microbial Dysbiosis in Colorectal Adenomas
por: Nugent, Julia L., et al.
Publicado: (2014)

Molecular characterization of colorectal adenoma and colorectal cancer via integrated genomic transcriptomic analysis
por: Pan, Peng, et al.
Publicado: (2023)

Molecular alterations in colorectal adenomas and intramucosal adenocarcinomas defined by high-density single-nucleotide polymorphism arrays
por: Eizuka, Makoto, et al.
Publicado: (2017)

Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
por: Hao, T B, et al.
Publicado: (2014)

The histomorphological and molecular landscape of colorectal adenomas and serrated lesions
por: Galuppini, Francesca, et al.
Publicado: (2021)

Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer
por: Philipp, Alexander B, et al.
Publicado: (2014)

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
por: Spindler, Karen Lise Garm, et al.
Publicado: (2015)

Correlations of morphology and molecular alterations in traditional serrated adenoma
por: Gui, Hongxing, et al.
Publicado: (2020)

Evaluation of the Possibility to Detect Circulating Tumor DNA From Pituitary Adenoma
por: Megnis, Kaspars, et al.
Publicado: (2019)

Therapeutic Actionability of Circulating Cell-Free DNA Alterations in Carcinoma of Unknown Primary
por: Kato, Shumei, et al.
Publicado: (2021)

Circulating cell-free DNA methylation mirrors alterations in cerebral patterns in epilepsy
por: Martins-Ferreira, Ricardo, et al.
Publicado: (2022)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

The Role of Exhaled Hydrogen Sulfide in the Diagnosis of Colorectal Adenoma
por: Liu, Nian, et al.
Publicado: (2021)

Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients
por: Yang, Ying-Chi, et al.
Publicado: (2018)

Circulating cell free DNA as the diagnostic marker for colorectal cancer: a systematic review and meta-analysis
por: Wang, Xin, et al.
Publicado: (2018)

Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma
por: Jacobs, Elizabeth, et al.
Publicado: (2011)

DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors
por: Song, Yipeng, et al.
Publicado: (2021)

Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib
por: Wong, Andrea Li Ann, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cdeo6ol3hq9usr7l1ecck3k8e0